Digma Medical

📍 Givat Shmuel, Israel🗓 Founded 2013👥 16 employees💰 Last funded 2019
Medical Equipment Manufacturing🌐 digmamedical.com
Website LinkedIn
Digma aims to harness the power of the small intestine to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that dramatically improve their quality of life and long-term health outcomes. We are developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling . Our product is compatible with standard gastrointestinal endoscopes and the EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. Our goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy. The EGM procedure is currently being evaluated in clinical studies. To learn more about our clinical program, please contact us.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Digma Medical?
Digma Medical has 1 investors on record on gritt.io and 1 late-stage investors.
When did Digma Medical last raise funding?
The most recent investment in Digma Medical recorded on gritt.io was in 2019.
When was Digma Medical founded?
Digma Medical was founded in 2013.
What industry is Digma Medical in?
Digma Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Digma Medical based?
Digma Medical is headquartered in Givat Shmuel, Israel.